Thomas Leggett
Director/Board Member chez RESEARCH ALLIANCE CORP. II
Fortune : 15 756 $ au 31/03/2024
Profil
Thomas Leggett is currently working as an Independent Director at Research Alliance Corp.
II, as an Independent Non-Executive Director at Clover Biopharmaceuticals Ltd., and as the Chief Financial Officer at Affinia Therapeutics, Inc. He previously worked as an Executive Director at UBS Securities LLC from 2009 to 2015, as the Treasurer & Head-Finance Business Development at Purdue Pharma LP in 2016, as the Chief Financial Officer & Senior VP-Finance at Axcella Health, Inc. from 2017 to 2019, and as the Chief Financial & Accounting Officer at Black Diamond Therapeutics, Inc. from 2019 to 2021.
Leggett received his undergraduate degree from The Trustees of Columbia University in The City of New York in 1999 and his MBA from The Wharton School of the University of Pennsylvania in 2004.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/04/2024 | 300 750 ( 0,02% ) | 15 756 $ | 31/03/2024 |
Postes actifs de Thomas Leggett
| Sociétés | Poste | Début |
|---|---|---|
| RESEARCH ALLIANCE CORP. II | Director/Board Member | 01/02/2021 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 19/04/2021 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Director of Finance/CFO | 01/12/2021 |
Anciens postes connus de Thomas Leggett
| Sociétés | Poste | Fin |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Director of Finance/CFO | 16/11/2021 |
| AXCA HEALPAR | Director of Finance/CFO | 30/08/2019 |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Treasurer | 01/12/2016 |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Director/Board Member | 01/05/2015 |
Formation de Thomas Leggett
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AXCA HEALPAR | Health Technology |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
Research Alliance Corp. II
 Research Alliance Corp. II Financial ConglomeratesFinance Research Alliance Corp. II operates as a blank check company. The company was founded by Peter Kolchinsky, Matthew Hammond and Tess Cameron on July 17, 2020 and is headquartered in Las Vegas, NV. | Finance |
